PRME — Prime Medicine, Inc. stock price, charts and financials

QT13Prime Medicine, Inc.

Prime Medicine, Inc. (NASDAQ: PRME) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
2.98
+0.17+6.05%
OverviewShort InterestFilings
PRMEQT13Prime Medicine, Inc.·NASDAQ
2.98+6.05%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 03, 2026485BXT485BXT
Aug 03, 2026485BXT485BXT
Aug 03, 2026485BXT485BXT
Jul 31, 2026485BXT485BXT
Jul 31, 2026485BXT485BXT
Jul 31, 2026485BXT485BXT
Jul 30, 2026497KSummary prospectus
Jul 30, 2026497Definitive prospectus
Jul 28, 2026485APOS485APOS
Jul 22, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 22, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 17, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 17, 2026485BXT485BXT
Jul 17, 2026485BXT485BXT
Jul 17, 2026485BXT485BXT
Jul 17, 2026485BXT485BXT
Jul 17, 2026485BXT485BXT
Jul 17, 2026485BXT485BXT
Jul 17, 2026485BXT485BXT
Jul 17, 2026485BXT485BXT
Jul 17, 2026485BXT485BXT
Jul 17, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 17, 2026485BXT485BXT
Jul 17, 2026485BXT485BXT
Jul 17, 2026485BXT485BXT
#1 / 25 of 585
Page
▼
/ 24